Rutgers Cancer Institute Offers Clinical Trial Examining Potential Treatment for COVID-19
April 04, 2020
April 04, 2020
NEW BRUNSWICK, New Jersey, April 4 -- Rutgers Cancer Institute of New Jersey issued the following news:
* * *
- Combination of malaria drug and antibiotic being explored
* * *
Rutgers Cancer Institute of New Jersey, a National Cancer Institute-designated Comprehensive Cancer Center, is offering a clinical trial as a potential treatment for patients diagnosed with the coronavirus (COVID-19). The trial, which is being offered at Rutgers Cancer In . . .
* * *
- Combination of malaria drug and antibiotic being explored
* * *
Rutgers Cancer Institute of New Jersey, a National Cancer Institute-designated Comprehensive Cancer Center, is offering a clinical trial as a potential treatment for patients diagnosed with the coronavirus (COVID-19). The trial, which is being offered at Rutgers Cancer In . . .